The U.S. Food and Drug Administration has approved the first vaginal ring contraceptive that can be used for an entire year. Annovera (segesterone acetate and ethinyl estradiol vaginal system), from TherapeuticsMD, is a long-acting prescription birth control device that is patient-controlled, procedure-free and reversible. The Annovera contraceptive vaginal system is a small, soft flexible ring that prevents ovulation for an entire year (13 cycles) and can be inserted and removed by a woman at her discretion in repeated four-week cycles. It is intended to remain in place continuously for three weeks followed by removal for one week, at which time women may experience a period (or withdrawal bleed).
“The U.S. contraceptive market is shifting toward long-acting solutions and we believe ANNOVERA represents an exciting new entrant for women and healthcare providers by providing the first woman-controlled, procedure-free, long-acting, reversible birth control product putting the woman in control of both her fertility and menstruation,” said Dr. Brian Bernick, Co-Founder of TherapeuticsMD. “We believe ANNOVERA can help meet the needs of women who are looking for long-acting solutions, including women who have never given birth and women who are not in a monogamous relationship, who are often counseled not to use many of the currently available long-acting contraceptive products.”
Pages: 1 2